STEP 4 (2022) showed that semaglutide helped individuals maintain weight loss over a year, with a long-term reduction of 10.3% in body weight even after discontinuation of the medication
Rob Whitfield for his own patients
Avoid high-fat, greasy, and heavily spiced foods during the first 2 weeks at a new dose
Several GLS inhibitors have been developed, among which CB-839 is currently undergoing clinical trials as a potent, orally bioavailable GLS-selective inhibitor for the treatment of various cancers, including TNBC, NSCLC, and colon cancer (NCT03057600, NCT03057600, NCT03057600, NCT03057600, NCT03057600, NCT03057600)
When you participate in our programs, you gain access to a dedicated team that understands the nuances of GLP-1 therapy